Jinhe Biotechnology CO., LTD.



Quote for Jinhe Biotechnology CO., LTD.

Last Trade:
-
Change:
--
Symbol/Code:
002688
Status:
-
Stock Type:
A Share
Market Cap:
-
Open:
-
Prev Close:
-
Bid:
-
Ask:
-
Volume(*100):
-
Amount:
-
Limit Up:
-
Limit Down:
-
Day's Range:
-
P/E(ttm):
-
P/B ratio
-
Update:-
Currency in CNY Time=UTC+8002688 quote

Summary for Jinhe Biotechnology CO., LTD.

Jinhe Biotechnology Co., Ltd is principally engaged in the manufacture and distribution of pharmaceutical feedstuff additives. The Company primarily provides aureomycin for feedstuffs, chlortetracycline and salinomycin, among others. Its products are primarily applied as feedstuff additives, which is used for preventing animals from certain diseases, the acceleration of animals' growth and the promotion of feedstuff conversion rate. The Company distributes its products in domestic and overseas markets, such as the United States, Vietnam, Europe and Central Asia.

Profile for Jinhe Biotechnology CO., LTD.

Full Name:Jinhe Biotechnology CO., LTD.
Full Name in Chinese:金河生物科技股份有限公司 Short Name in Chinese:金河生物
Symbol/Stock Code:
002688
Listed in:
Shenzhen Stock Exchange
Issued Capital
-
Negotiable Capital:
-
Chairman:
Wang Dongxiao
Secretary of the Board:
Deng Yixin
Phone:
+86-471-8524005
Fax:
+86-471-8524039
Official Website:www.jinhe.com.cn
E-mail:jinhe@jinhe.com.cn
Address:No. 71,Xinping Road, Tuoketuo County,HUHEHAOTE 010200
IPO Subscription Date:
2012-07-05
Listing Date:
2012-07-13
IPO Issued Capital:
27230000
IPO Price:
18
IPO fees:
36561400 CNY
Money Raised by IPO:
490140000 CNY
IPO Par Value:
1.00 CNY
Net Money Raised:
453578600 CNY
Open(Listing day):
- CNY
Close(Listing day):
- CNY
Diluted P/E ratio after IPO:
26.8700
Turnover rate(listing day):
-%

Financials for Jinhe Biotechnology CO., LTD.

UPDATE:2012-10-21 Annual Report Abstract:(All Currency In CNY)

Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Net Profit(after tax)(Million)
60.1966
77.4048
52.7539
27.0278
Net Profit Growth(%)
18.69
46.72
95.18
70.31
Return On Equity(ROE)(%)
7.21
24.00
21.77
14.62
Debt ratio(%)
18.69
50.15
59.15
68.31
Net Operating Cash Flow/Net Profit(%)
125.37
137.71
223.77
85.82

Per Share Financial Data:(All Currency In CNY)

Per Share Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Earnings Per Share(EPS)
0.6900
0.9475
0.6458
0.3309
Diluted Earnings Per Share
0.0000
0.8974
0.6142
0.3237
Net Asset Value Per Share (NAVPS)
9.5200
3.9500
2.9700
2.2600
Additional Paid-In Capital Per Share
4.5705
0.8895
0.8528
0.7950
Retained Earnings Per Share
1.9255
1.8304
0.9840
0.4058
Net Cash Flow From Operatings Activities Per Share
0.6900
1.3050
1.4450
0.2840
Net Cash Flow Per Share
3.0634
0.3243
-0.1969
0.0691

Balance Sheet:(All Currency In CNY)

Assets And Liabilities/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Total Assets(Million)
1026.8114
670.8391
623.9228
618.5884
Total Liabilities(Million)
191.9533
336.4382
369.0936
422.559
Current Liabilities(Million)
173.905
315.1641
306.4018
406.6722
Long Term Liabilities(Million)
-
-
-
-
Cash And Cash Equivalents(Million)
421.5081
87.8444
61.3538
77.439
Accounts Receivables(Million)
116.4735
108.3674
82.4705
83.3168
Deposit Received(Million)
2.0831
10.2749
1.227
2.8381
Other Receivables(Million)
15.5047
9.5342
7.4525
7.8193
Bad Debt Reserve(Million)
-
-
-
-
Shareholder's Equity/Owner's Equity(Million)
834.8915
322.4981
242.2896
184.8396
Debt ratio(%)
18.69
50.15
59.15
68.31
Equity Ratio(%)
81.3000
48.0700
38.8300
29.8800
Current Ratio
4.0072
1.0310
0.8896
0.7496
Quick Ratio
3.3478
0.6915
0.5194
0.4826

Cash Flow Statement:(All Currency In CNY)

Cash Flow/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Cash From Selling Commodities(Million)
540.2999
728.9268
616.2605
480.4951
Net Cash Flow From Operatings Activities(Million)
75.4691
106.5908
118.0492
23.1953
Net Cash Flow From Operatings Activities Change(%)
196.45
-9.71
408.94
99.32
Net Cash Flow(Million)
333.6637
26.4906
-16.0852
5.6484
Cash From Selling Commodities/Prime Revenue(%)
98.52
101.14
104.41
104.74
Net Cash Flow/Net Profit(%)
554.29
34.22
-30.49
20.90
Cash Flow From Investing Activities(Million)
-38.6192
-39.4975
-54.8726
-23.0022
Cash Flow From Financing Activities(Million)
296.8166
-40.5478
-79.2394
5.4527

Income Statement:(All Currency In CNY)

Income Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Prime Operating Revenue(Million)
548.436
720.7265
590.2183
458.7519
Prime Operating Profit(Million)
-
-
-
-
Operating Costs(Million)
31.2312
40.9385
35.9176
28.2824
Administrative Costs(Million)
57.234
85.4662
64.7394
42.7775
Financing Costs(Million)
10.7589
19.1182
17.825
14.3585
Above Three Costs Change(%)
0.30
22.82
38.71
11.87
Operating Profit(Million)
68.638
87.3343
61.5409
31.7432
Income From Investment(Million)
-
-
0.0017
-
Government Subsidies(Million)
-
-
-
-
Net Non-Operating Income And Expense(Million)
3.7503
4.1047
2.6458
0.4198
Total Profit(Million)
72.3883
91.439
64.1868
32.163
Corporate Income Tax(Million)
11.4571
14.5112
10.9725
6.1218
Net Profit(Million)
60.1966
77.4048
52.7539
27.0278
Gross Profit Ratio(%)
31.61
33.57
31.44
25.82
Operating Margin(%)
12.51
12.11
10.42
6.91
Return On Equity(ROE)(%)
7.21
24.00
21.77
14.62

Announcements for Jinhe Biotechnology CO., LTD.

Date: 2012-09-12
Title: EGM RESOLUTION
The Company held its 1st Extraordinary General Meeting of 2012 on 11 September 2012, during which the following proposal(s) was/were approved:
1. Amendments to the Company's articles of association
2. To replenish working capital with idle raised funds
Date: 2012-07-12
Title: IPO SHARE LISTING
The Company's 27.23 million shares (code:002688) in its initial public offering will be listed on the Shenzhen Stock Exchange on 13 July 2012.
Date: 2012-07-04
Title: IPO-ONLINE SUBSCRIPTION
Jinhe Biotechnology Co., Ltd. has been approved by the China Securities Regulatory Commission (the CSRC) to issue 27.230000 million A-shares in its initial public offering.
1. Class: A shares
2. Stock code: 002688
3. Stock abbreviation: Jinhe Biotechnology
4. Issuing volume: 27.230000 million shares
5. Par value: CNY1.00 per share
6. Issuing mechanism: a book building process will be conducted with a combination of online public offering and offline placement.
7. Targeted listing bourse: Shenzhen Stock Exchange
8. Offline placement volume: 13.620000 million shares
9. Online offering volume: 13.610000 million shares
10. Price: CNY18.00 per share
11. Offline subscription period: 05 July 2012
12. Online subscription date: 05 July 2012.
Date: 2012-06-26
Title: IPO
Jinhe Biotechnology Co., Ltd. has been approved by the China Securities Regulatory Commission (the CSCR) to issue 27.2300 million A-shares in its initial public offering, which is structured as follows:
1.Class: A shares
2.Size: 27.2300 million shares
3.Par value: CNY1.00 per share
4.Issuing mechanism: a book building process will be conducted with a combination of online public offering and offline placement.
5.Targeted listing bourse: Shenzhen Stock Exchange
6.Offline placement volume: 13.6200 million shares
7.Online offering volume:13.6100 million shares
8.IPO price inquiry period: from 27 June 2012 to 02 July 2012
9.IPO price determined: 04 July 2012
10.Offline subscription date:05 July 2012
11.Online subscription date: 05 July 2012
12.Expected listing date:N/A.